Sara Balletta

发表

Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis

D. Centonze, M. S. Bassi, G. Mandolesi, 2022, Neurobiology of Disease.

The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis

D. Centonze, G. Mandolesi, R. Furlan, 2021, Cells.

Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis

D. Centonze, M. S. Bassi, G. Mandolesi, 2021, Brain, Behavior, and Immunity.

Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis

D. Centonze, G. Mandolesi, F. Buttari, 2020, International journal of molecular sciences.

Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis

D. Centonze, G. Mandolesi, F. Buttari, 2020, Cells.

CXCR2 increases in ALS cortical neurons and its inhibition prevents motor neuron degeneration in vitro and improves neuromuscular function in SOD1G93A mice

F. Mammano, E. Aronica, S. Cavallaro, 2021, Neurobiology of Disease.

Re-Examining the Role of TNF in MS Pathogenesis and Therapy

D. Centonze, G. Mandolesi, F. Buttari, 2020, Cells.

MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis

D. Centonze, C. Procaccini, G. Matarese, 2021, Neuropathology and applied neurobiology.

Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis

D. Centonze, G. Mandolesi, F. Buttari, 2020, Frontiers in Cellular Neuroscience.

Lipocalin-2 promotes adipose–macrophage interactions to shape peripheral and central inflammatory responses in experimental autoimmune encephalomyelitis

D. Centonze, K. Suk, D. Fresegna, 2023, Molecular metabolism.

Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis

G. Mandolesi, A. Finardi, F. Buttari, 2024, Frontiers in Molecular Neuroscience.

Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis

E. Volpe, G. Mandolesi, F. Buttari, 2024, Journal of neuroinflammation.

An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis

G. Mandolesi, A. Finardi, F. Buttari, 2024, International Journal of Molecular Sciences.

Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis

G. Mandolesi, Anto Pavlović, A. Musella, 2024, Neuropharmacology.

MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis

D. Centonze, M. S. Bassi, G. Mandolesi, 2023, Current neuropharmacology.

Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity

G. Mandolesi, A. Finardi, F. Buttari, 2024, International journal of molecular sciences.